Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 133

1.

Changes in ubiquitin proteasome pathway gene expression in skeletal muscle with exercise and statins.

Urso ML, Clarkson PM, Hittel D, Hoffman EP, Thompson PD.

Arterioscler Thromb Vasc Biol. 2005 Dec;25(12):2560-6. Epub 2005 Oct 13.

PMID:
16224050
[PubMed - indexed for MEDLINE]
Free Article
2.

The creatine kinase response to eccentric exercise with atorvastatin 10 mg or 80 mg.

Kearns AK, Bilbie CL, Clarkson PM, White CM, Sewright KA, O'Fallon KS, Gadarla M, Thompson PD.

Atherosclerosis. 2008 Sep;200(1):121-5. doi: 10.1016/j.atherosclerosis.2007.12.029. Epub 2008 Feb 7.

PMID:
18261731
[PubMed - indexed for MEDLINE]
3.

Effect of atorvastatin on energy expenditure and skeletal muscle oxidative metabolism at rest and during exercise.

Chung J, Brass EP, Ulrich RG, Hiatt WR.

Clin Pharmacol Ther. 2008 Feb;83(2):243-50. Epub 2007 Jun 6.

PMID:
17554242
[PubMed - indexed for MEDLINE]
4.

Effect of statins on skeletal muscle function.

Parker BA, Capizzi JA, Grimaldi AS, Clarkson PM, Cole SM, Keadle J, Chipkin S, Pescatello LS, Simpson K, White CM, Thompson PD.

Circulation. 2013 Jan 1;127(1):96-103. doi: 10.1161/CIRCULATIONAHA.112.136101. Epub 2012 Nov 26.

PMID:
23183941
[PubMed - indexed for MEDLINE]
Free Article
5.

Increases in creatine kinase with atorvastatin treatment are not associated with decreases in muscular performance.

Ballard KD, Parker BA, Capizzi JA, Grimaldi AS, Clarkson PM, Cole SM, Keadle J, Chipkin S, Pescatello LS, Simpson K, White CM, Thompson PD.

Atherosclerosis. 2013 Sep;230(1):121-4. doi: 10.1016/j.atherosclerosis.2013.07.001. Epub 2013 Jul 13.

PMID:
23958263
[PubMed - indexed for MEDLINE]
6.

A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscle.

Laaksonen R, Katajamaa M, Päivä H, Sysi-Aho M, Saarinen L, Junni P, Lütjohann D, Smet J, Van Coster R, Seppänen-Laakso T, Lehtimäki T, Soini J, Oresic M.

PLoS One. 2006 Dec 20;1:e97.

PMID:
17183729
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Human skeletal muscle drug transporters determine local exposure and toxicity of statins.

Knauer MJ, Urquhart BL, Meyer zu Schwabedissen HE, Schwarz UI, Lemke CJ, Leake BF, Kim RB, Tirona RG.

Circ Res. 2010 Feb 5;106(2):297-306. doi: 10.1161/CIRCRESAHA.109.203596. Epub 2009 Nov 25.

PMID:
19940267
[PubMed - indexed for MEDLINE]
Free Article
8.

A randomized clinical trial to assess the effect of statins on skeletal muscle function and performance: rationale and study design.

Thompson PD, Parker BA, Clarkson PM, Pescatello LS, White CM, Grimaldi AS, Levine BD, Haller RG, Hoffman EP.

Prev Cardiol. 2010 Summer;13(3):104-11. doi: 10.1111/j.1751-7141.2009.00063.x.

PMID:
20626664
[PubMed - indexed for MEDLINE]
9.

Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia.

Draeger A, Monastyrskaya K, Mohaupt M, Hoppeler H, Savolainen H, Allemann C, Babiychuk EB.

J Pathol. 2006 Sep;210(1):94-102.

PMID:
16799920
[PubMed - indexed for MEDLINE]
10.

Skeletal muscle cell MHC I expression: implications for statin-induced myopathy.

Singh P, Kohr D, Kaps M, Blaes F.

Muscle Nerve. 2010 Feb;41(2):179-84. doi: 10.1002/mus.21479.

PMID:
19813190
[PubMed - indexed for MEDLINE]
11.

[Statin therapy and muscle disorders].

Abel T, Fehér J.

Orv Hetil. 2009 Feb 8;150(6):261-3. doi: 10.1556/OH.2009.28520. Hungarian. No abstract available.

PMID:
19179258
[PubMed - indexed for MEDLINE]
Free Article
12.

No adverse effects of statins on muscle function and health-related parameters in the elderly: an exercise study.

Panayiotou G, Paschalis V, Nikolaidis MG, Theodorou AA, Deli CK, Fotopoulou N, Fatouros IG, Koutedakis Y, Sampanis M, Jamurtas AZ.

Scand J Med Sci Sports. 2013 Oct;23(5):556-67. doi: 10.1111/j.1600-0838.2011.01437.x. Epub 2012 Jan 31.

PMID:
22288788
[PubMed - indexed for MEDLINE]
13.

The genetic determinants of atorvastatin response.

Rodrigues AC, Hirata MH, Hirata RD.

Curr Opin Mol Ther. 2007 Dec;9(6):545-53. Review.

PMID:
18041665
[PubMed - indexed for MEDLINE]
14.

Regulation of the ubiquitin proteasome system in mechanically injured human skeletal muscle.

Seiffert M, Gosenca D, Ponelies N, Ising N, Patel MB, Obertacke U, Majetschak M.

Physiol Res. 2007;56(2):227-33. Epub 2006 Mar 23.

PMID:
16555940
[PubMed - indexed for MEDLINE]
Free Article
15.

Glucocorticoid receptor and ubiquitin expression after repeated eccentric exercise.

Willoughby DS, Taylor M, Taylor L.

Med Sci Sports Exerc. 2003 Dec;35(12):2023-31.

PMID:
14652497
[PubMed - indexed for MEDLINE]
16.

Modulation of the ubiquitin-proteasome proteolytic pathway by eicosapentaenoic acid supplementation in a model of progressive malignancy.

Mikhail AT, Babcock TA, Jho DH, Helton WS, Brodsky IG, Espat NJ.

JPEN J Parenter Enteral Nutr. 2003 Mar-Apr;27(2):105-9.

PMID:
12665165
[PubMed - indexed for MEDLINE]
17.

Statin-associated myopathy and its exacerbation with exercise.

Meador BM, Huey KA.

Muscle Nerve. 2010 Oct;42(4):469-79. doi: 10.1002/mus.21817. Review.

PMID:
20878737
[PubMed - indexed for MEDLINE]
18.

Effects of aerobic training on gene expression in skeletal muscle of elderly men.

Radom-Aizik S, Hayek S, Shahar I, Rechavi G, Kaminski N, Ben-Dov I.

Med Sci Sports Exerc. 2005 Oct;37(10):1680-96.

PMID:
16260967
[PubMed - indexed for MEDLINE]
19.

Contributions of the ubiquitin-proteasome pathway and apoptosis to human skeletal muscle wasting with age.

Whitman SA, Wacker MJ, Richmond SR, Godard MP.

Pflugers Arch. 2005 Sep;450(6):437-46. Epub 2005 Jun 11.

PMID:
15952031
[PubMed - indexed for MEDLINE]
20.

Comparative safety of atorvastatin 80 mg versus 10 mg derived from analysis of 49 completed trials in 14,236 patients.

Newman C, Tsai J, Szarek M, Luo D, Gibson E.

Am J Cardiol. 2006 Jan 1;97(1):61-7. Epub 2005 Nov 15.

PMID:
16377285
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk